2 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow CyberKnife: new trials by email Literature Review of CyberKnife trials Research Report on CyberKnife
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) Gemcitabine, nab-paclitaxel, CyberKnife - Pancreas Cancer, Pancreatic Cancer | Phase 1 | Terminated | The Cooper Health System | 30 | 2015-01-01 | 2019-07-30 |
| Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer Stereotactic body radiotherapy (SBRT) - Breast Neoplasm | Phase 1 | Unknown | Juravinski Cancer Center | 32 | 2014-02-01 | 2015-03-31 |
| Radiosurgery for Glioblastoma Multiforme CyberKnife - Glioblastoma Multiforme | Phase 1 / Phase 2 | Terminated | Beth Israel Deaconess Medical Center | 4 | 2007-02-01 | 2017-03-06 |
Breast Neoplasms (1) · Glioblastoma (1) · Pancreatic Neoplasms (1)
Beth Israel Deaconess Medical Center (1) · Juravinski Cancer Center (1) · The Cooper Health System (1)
United States (2) · Canada (1)
Anand Mahadevan, MD (1) · Do-Hoon Kim, BASc, MD, MSc, FRCPC (1) · Julie Arsenault, MD, FRCPC (1) · Timothy Whelan, BSc, BM,BCh, MSc, FRCPC (1)